ALL

Conference Coverage

Enrollment stalled for CAR T-cell study

Memorial Sloan-Kettering Cancer Center has temporarily suspended enrollment in a study of chimeric antigen receptor (CAR) T-cell therapy, due to 2...

News

Ponatinib back on the market

Ariad Pharmaceuticals, Inc., has begun shipping the drug to Biologics, Inc., its exclusive specialty pharmacy.

News

Genetic events drive ALL subtype

a patient with ALL Investigators have identified the genetic events leading to leukemic transformation in ETV6-RUNX1 acute lymphoblastic leukemia...

Pages